> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 2 Drug Substance Nixed For Compounding
- URL: https://www.fdaweb.com/2-drug-substance-nixed-for-compounding/
- Published: 2023-08-21T12:00:00.000Z
- Updated: 2026-09-14T18:51:46.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5155144

*Federal Register* notice: FDA has identified two drug substances that will not be added to its list of bulk drug substances (active pharmaceutical ingredients) that are acceptable for drug compounding —ephedrine sulfate and hydroxychloroquine sulfate. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-08-21/pdf/2023-17881.pdf?ref=fdaweb.com).